SCHEMBL5358055

SCHEMBL5358055

N#CC1CCC(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31080344 1.00
SCHEMBL10836378 0.85 KDM2B (0.38)
SCHEMBL10836372 0.85 KDM2B (0.38)
SCHEMBL4481298 0.84
SCHEMBL4476126 0.84
SCHEMBL4476120 0.84
SCHEMBL4481295 0.84
SCHEMBL4476125 0.84
SCHEMBL9435893 0.82
SCHEMBL4469185 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747258-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-27 EP disclosed
US-20250136606-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2025-05-01 US disclosed
WO-2025024329-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-30 WO disclosed
EP-4408850-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2024-08-07 EP disclosed
CN-118317963-A TRPML modulators, compositions thereof, and methods of use 卡拉韦治疗公司 2024-07-09 CN disclosed
EP-4317160-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Kumiai Chemical Industry Co., Ltd. (JP) 2024-02-07 EP disclosed
US-11879109-B2 Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium RESONAC CORPORATION (JP) 2024-01-23 US disclosed
CN-114341094-B Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium 株式会社力森诺科 2024-01-12 CN disclosed
CN-117098759-A Heterocyclic compounds and their use 组合化学工业株式会社 2023-11-21 CN disclosed
WO-2023055920-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2023-04-06 WO disclosed
US-6699695-B1 FOR EXAMPLE, CONVERTING 2-HYDROXY-4-METHYLTHIOBUTYRONITRILE INTO THE CORRESPONDING AMIDE, WHICH IS A PRECURSOR TO THE FEED SUPPLEMENT 2-HYDROXY-4-METHYLTHIOBUTYRIC ACID DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-6504044-B2 Reacting cyclohexanone with the carbanions of an aryl acetonitrile using a base, isolating and purifying 1-(cyano(aryl)methyl) cyclohexanol compound by crystallization COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-01-07 US disclosed
EP-1238967-A1 A process for the preparation of 1-(cyano(aryl)methyl) cyclohexanol Council of Scientific and Industrial Research (IN) 2002-09-11 EP disclosed
US-20020120164-A1 Process for the preparation of 1-[cyano(aryl)methyl] cyclohexanol COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2002-08-29 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
US-20020058201-A1 Radiation-sensitive resin composition JSR CORPORATION (JP) 2002-05-16 US disclosed
EP-1193558-A2 Radiation-sensitive resin composition JSR Corporation (JP) 2002-04-03 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed
CN-1290296-A Novel microorganisms and process for producing DAICEL CHEM (JP) 2001-04-04 CN disclosed
EP-1055724-A1 MICROORGANISMS AND PROCESS FOR PRODUCING AMIDE COMPOUNDS Daicel Chemical Industries, Ltd. (JP) 2000-11-29 EP disclosed